What Do We Currently Know About Chronic Myeloid Leukemia (CML) and COVID-19?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
https://link.springer.com/content/pdf/10.1007/s11912-021-01169-w.pdf
Reference26 articles.
1. Rafiq D, Batool A, Bazaz M. Three months of COVID -19: a systematic review and meta-analysis. Rev Med Virol. 2020;30: e2113. https://doi.org/10.1002/rmv.2113.
2. Ashour H, Elkhatib W, Rahman M, Elshabrawy H. Insights into the recent 2019 novel coronavirus (SARS-CoV-2) in light of past human coronavirus outbreaks. Pathogens. 2020;9:186. https://doi.org/10.3390/pathogens9030186.
3. Who.int. 2021. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. [online] Available at: [Accessed 16 April 2021]. (2021)
4. Johns Hopkins Coronavirus Resource Center. 2021. COVID-19 Map - Johns Hopkins Coronavirus Resource Center. [online] Available at: [Accessed 16 April 2021].
5. Yu J, Ouyang W, Chua M, Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan. China JAMA Oncology. 2020;6:1108–10. https://doi.org/10.1001/jamaoncol.2020.0980.
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Managing and treating COVID-19 in patients with hematological malignancies: a narrative review and expert insights;Clinical and Experimental Medicine;2024-06-04
2. COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches;Cell Communication and Signaling;2024-02-15
3. Advances in the Treatment of Chronic Myeloid Leukemia;Recent Patents on Anti-Cancer Drug Discovery;2024-02
4. Omicron related COVID-19 prevention and treatment measures for patients with hematological malignancy and strategies for modifying hematologic treatment regimes;Frontiers in Cellular and Infection Microbiology;2023-10-19
5. Clinical Outcomes of Patients with Chronic Myeloid Leukemia and COVID-19 Infection—A Single Center Survey;Medicina;2023-08-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3